HOXD13 and myelodysplastic syndrome: In addition, SETD2 deficiency enhanced hematopoietic stem cell signaling and decreased myeloid differentiation pathways in hematopoietic stem and progenitor cells from NUP98-hoxd13 (NDH13) transgenic mice in a myelodysplastic syndrome (MDS) model79.